1. Home
  2. JBSS vs NTLA Comparison

JBSS vs NTLA Comparison

Compare JBSS & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBSS
  • NTLA
  • Stock Information
  • Founded
  • JBSS 1959
  • NTLA 2014
  • Country
  • JBSS United States
  • NTLA United States
  • Employees
  • JBSS N/A
  • NTLA N/A
  • Industry
  • JBSS Specialty Foods
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • JBSS Consumer Staples
  • NTLA Health Care
  • Exchange
  • JBSS Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • JBSS 799.9M
  • NTLA 1.0B
  • IPO Year
  • JBSS 1991
  • NTLA 2016
  • Fundamental
  • Price
  • JBSS $74.58
  • NTLA $10.35
  • Analyst Decision
  • JBSS
  • NTLA Buy
  • Analyst Count
  • JBSS 0
  • NTLA 18
  • Target Price
  • JBSS N/A
  • NTLA $39.44
  • AVG Volume (30 Days)
  • JBSS 76.7K
  • NTLA 3.7M
  • Earning Date
  • JBSS 04-30-2025
  • NTLA 02-27-2025
  • Dividend Yield
  • JBSS 4.16%
  • NTLA N/A
  • EPS Growth
  • JBSS N/A
  • NTLA N/A
  • EPS
  • JBSS 4.16
  • NTLA N/A
  • Revenue
  • JBSS $1,118,719,000.00
  • NTLA $57,877,000.00
  • Revenue This Year
  • JBSS N/A
  • NTLA N/A
  • Revenue Next Year
  • JBSS N/A
  • NTLA N/A
  • P/E Ratio
  • JBSS $17.92
  • NTLA N/A
  • Revenue Growth
  • JBSS 12.09
  • NTLA 59.55
  • 52 Week Low
  • JBSS $68.56
  • NTLA $8.30
  • 52 Week High
  • JBSS $108.96
  • NTLA $32.00
  • Technical
  • Relative Strength Index (RSI)
  • JBSS 50.81
  • NTLA 48.83
  • Support Level
  • JBSS $70.67
  • NTLA $8.30
  • Resistance Level
  • JBSS $73.18
  • NTLA $10.37
  • Average True Range (ATR)
  • JBSS 1.65
  • NTLA 0.98
  • MACD
  • JBSS 0.75
  • NTLA -0.08
  • Stochastic Oscillator
  • JBSS 78.23
  • NTLA 45.15

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and under the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also market and distribute, and in the majority of cases, manufacture or process, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: